. . . "nutraceutical"@en . . . . . "9000-38-8"@en . . . . . . . . . . "Kava"@en . . . . "# Uebelhack R, Franke L, Schewe HJ: Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry. 1998 Sep;31(5):187-92. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9832350 # Baum SS, Hill R, Rommelspacher H: Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1105-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9829291 # Seitz U, Schule A, Gleitz J: [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Med. 1997 Dec;63(6):548-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9434608 # Lim ST, Dragull K, Tang CS, Bittenbender HC, Efird JT, Nerurkar PV: Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci. 2007 May;97(1):214-21. Epub 2007 Feb 27. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/17329236 # Sorrentino L, Capasso A, Schmidt M: Safety of ethanolic kava extract: Results of a study of chronic toxicity in rats. Phytomedicine. 2006 Sep;13(8):542-9. Epub 2006 Aug 14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16904878"@en . . . . . . . . . . "Klaus-Peter Schwabe, \"Kava-kava extract, process for the production thereof and use thereof.\" U.S. Patent US5296224, issued November, 1963."@en . . . . . . . . .